REFERENCES
- Li , D. , Xie , K. , Wolff , R. and Abbruzzese , J. L. 2004 . Pancreatic cancer . Lancet , 363 : 1049 – 1057 .
- Abbruzzese , J. L. 2002 . New applications of gemcitabine and future directions in the management of pancreatic cancer . Cancer , 95 ( Suppl. 4 ) : 941 – 945 .
- Burris , H. A. 3rd. , Moore , M. J. Andersen , J. 1995 . Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial . J. Clin. Oncol. , 15 : 2403 – 2413 .
- Saif , M. W. 2006 . Pancreatic Cancer: Highlights from the 42nd annual meeting of the American Society of Clinical Oncology 2006 . J. Pancreas , 7 : 337 – 348 .
- Pierantoni , C. , Pagliacci , A. Scartozzi , M. 2008 . Pancreatic cancer: progress in cancer therapy . Crit. Rev. Oncol. Hematol. , 67 : 27 – 38 .
- Sakorafas , G. H. , Tsiotou , A. G. and Tsiotos , G. G. 2000 . Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective . Cancer Treat. Rev. , 26 : 29 – 52 .
- Modrak , D. E. , Leon , E. , Goldenberg , D. M. and Gold , D. V. 2009 . Ceramide regulates gemcitabine-induced senescence and apoptosis in human pancreatic cancer cell lines . Mol. Cancer Res. , 7 : 890 – 6 .
- Giovannetti , E. , Del Tacca , M. Mey , V. 2006 . Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine . Cancer Res. , 66 : 3928 – 35 .
- Peters , G. J. , Van Der Wilt , C. L. van Moorsel , C. J. 2000 . Basis for effective combination cancer chemotherapy with antimetabolites . Pharmacol. Ther. , 87 : 227 – 53 .
- Macchia , M. , Barontini , S. Bertini , S. 2001 . Design, synthesis, and characterization of the antitumor activity of novel ceramide analogues . J. Med. Chem. , 44 : 3994 – 4000 .
- Tibaldi , C. , Giovannetti , E. Vasile , E. 2008 . Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients . Clin. Cancer Res. , 14 : 1797 – 803 .
- Hait , N. C. , Oskeritzian , C. A. Paugh , S. W. 2006 . Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases . Biochim. Biophys. Acta , 1758 : 2016 – 26 .
- Guillermet-Guibert , J. , Davenne , L. Pchejetski , D. 2009 . Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug . Mol. Cancer. Ther. , 8 : 809 – 20 .